The genetics of the p53 pathway, apoptosis and cancer therapy

p53: A new player in reproduction

(2010) Wenwei Hu et al.   CELL CYCLE

SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a

(2008) I. Seyfried et al.   BLOOD

Updates on p53: modulation of p53 degradation as a therapeutic approach

(2008) A Dey et al.   BRITISH JOURNAL OF CANCER

Association ofp53codon 72 polymorphism andMDM2SNP309 with clinical outcome of advanced nonsmall cell lung cancer

(2008) Ji-Youn Han et al.   CANCER

Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients

(2008) S. Cattelani et al.   CLINICAL CANCER RESEARCH

MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis

(2008) K. Asomaning et al.   CLINICAL CANCER RESEARCH

p53: A Guide to Apoptosis

(2008) Erik Meulmeester et al.   CURRENT CANCER DRUG TARGETS

MDM2 SNP309 Is Associated With Poor Outcome in B-Cell Chronic Lymphocytic Leukemia

(2008) Irina Gryshchenko et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptional control of human p53-regulated genes

(2008) Todd Riley et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

MDM2 SNP 309 and codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation

(2008) Hsi-Feng Tu et al.   RADIOTHERAPY AND ONCOLOGY